Zacks: Analysts Anticipate AAC Holdings Inc (AAC) Will Post Quarterly Sales of $84.48 Million
Equities analysts predict that AAC Holdings Inc (NYSE:AAC) will post sales of $84.48 million for the current quarter, according to Zacks. Two analysts have issued estimates for AAC’s earnings, with the highest sales estimate coming in at $85.50 million and the lowest estimate coming in at $83.47 million. AAC posted sales of $78.04 million during the same quarter last year, which would indicate a positive year over year growth rate of 8.3%. The business is scheduled to report its next quarterly earnings results on Wednesday, August 1st.
On average, analysts expect that AAC will report full year sales of $338.70 million for the current financial year, with estimates ranging from $336.50 million to $340.90 million. For the next fiscal year, analysts expect that the business will report sales of $390.40 million per share, with estimates ranging from $377.41 million to $403.40 million. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that cover AAC.
AAC (NYSE:AAC) last posted its earnings results on Wednesday, May 2nd. The company reported $0.13 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.12 by $0.01. The business had revenue of $78.50 million for the quarter, compared to analysts’ expectations of $75.92 million. AAC had a negative net margin of 6.25% and a positive return on equity of 9.76%. The business’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.12 EPS.
AAC traded up $0.72, hitting $10.08, during midday trading on Friday, according to Marketbeat. 248,125 shares of the company traded hands, compared to its average volume of 154,397. The company has a debt-to-equity ratio of 2.28, a quick ratio of 2.57 and a current ratio of 2.57. The stock has a market capitalization of $235.17 million, a P/E ratio of 15.53 and a beta of 1.34. AAC has a 52 week low of $5.99 and a 52 week high of $13.06.
In other news, CEO Michael T. Cartwright sold 61,000 shares of the stock in a transaction that occurred on Tuesday, May 22nd. The shares were sold at an average price of $11.95, for a total value of $728,950.00. Following the transaction, the chief executive officer now owns 2,719,099 shares in the company, valued at approximately $32,493,233.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director W Larry Cash acquired 5,000 shares of the stock in a transaction dated Monday, May 7th. The stock was acquired at an average price of $11.91 per share, for a total transaction of $59,550.00. Following the purchase, the director now directly owns 35,000 shares in the company, valued at $416,850. The disclosure for this purchase can be found here. 31.22% of the stock is currently owned by corporate insiders.
Large investors have recently modified their holdings of the company. Raymond James Financial Services Advisors Inc. bought a new position in shares of AAC in the 4th quarter worth approximately $114,000. The Manufacturers Life Insurance Company lifted its stake in shares of AAC by 234.9% in the 1st quarter. The Manufacturers Life Insurance Company now owns 10,724 shares of the company’s stock worth $123,000 after purchasing an additional 7,522 shares during the period. Deutsche Bank AG lifted its stake in shares of AAC by 154.1% in the 4th quarter. Deutsche Bank AG now owns 27,049 shares of the company’s stock worth $243,000 after purchasing an additional 16,404 shares during the period. Engineers Gate Manager LP bought a new position in shares of AAC in the 1st quarter worth approximately $247,000. Finally, Monarch Partners Asset Management LLC purchased a new stake in AAC in the 1st quarter worth approximately $250,000. Hedge funds and other institutional investors own 62.16% of the company’s stock.
AAC Company Profile
AAC Holdings, Inc provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAC and related companies with MarketBeat.com's FREE daily email newsletter.